Bright Minds Biosciences (DRUG) Share-based Compensation (IS) (2020 - 2026)
Bright Minds Biosciences (DRUG) recorded Share-based Compensation (IS) of $222,717 in fiscal Q3 2026 (quarter ended Jun 30, 2026), up 879.7% from $22,733 a year earlier and up 522.7% from the prior quarter.
Bright Minds Biosciences (DRUG) Share-based Compensation (IS) (2020 - 2026) Analysis & Trends
On a TTM basis, Bright Minds Biosciences' Share-based Compensation (IS) came in at $315,217 as of Jun 30, 2026, up 6.2% year-over-year; for FY2021 (ended Sep 30, 2021), it was $696,772, up 480.6% from FY2020.
- Across earlier fiscal years, Share-based Compensation (IS) came in at $120,003 in FY2020.
- The fiscal Q3 2026 figure is the highest quarterly Share-based Compensation (IS) since fiscal Q3 2023.
- Peak year-over-year performance for Share-based Compensation (IS) in the last five years was growth of 918.4% in fiscal Q3 2022, against a decline of 26.2% in fiscal Q2 2023 at the low end.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Stock Comp. (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | - |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | - |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | - |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | - |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | - |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | - |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | - |
| 10 | Bright Minds Biosciences | 380.42 Mn | 380.42 Mn | - | 222,716.65 |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 222,716.65 |
| Mar 31, 2026 | 35,767.54 |
| Dec 31, 2025 | 33,999.93 |
| Jun 30, 2025 | 22,732.50 |
| Mar 31, 2025 | 8,745.60 |
| Dec 31, 2024 | 1,828.99 |
| Jun 30, 2023 | 263,507.88 |
| Mar 31, 2023 | 195,954.44 |
| Dec 31, 2022 | 454,477.94 |
| Jun 30, 2022 | 191,592.46 |
| Mar 31, 2022 | 265,469.79 |
| Dec 31, 2021 | 250,767.98 |
| Sep 30, 2021 | 487,954.00 |
| Jun 30, 2021 | 18,813.63 |
| Mar 31, 2021 | 98,952.80 |
| Dec 31, 2020 | 90,522.42 |
Bright Minds Biosciences Share-based Compensation (IS) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DRUG&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "share-based-compensation-is", "ticker": "DRUG", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=share-based-compensation-is&ticker=DRUG&period=max&api_key=YOUR_API_KEY");
const data = await res.json();